Orli Wargon

3.7k total citations
53 papers, 1.3k citations indexed

About

Orli Wargon is a scholar working on Surgery, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Orli Wargon has authored 53 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Surgery, 18 papers in Pathology and Forensic Medicine and 14 papers in Oncology. Recurrent topics in Orli Wargon's work include Vascular Malformations and Hemangiomas (29 papers), Tumors and Oncological Cases (13 papers) and Vascular Malformations Diagnosis and Treatment (11 papers). Orli Wargon is often cited by papers focused on Vascular Malformations and Hemangiomas (29 papers), Tumors and Oncological Cases (13 papers) and Vascular Malformations Diagnosis and Treatment (11 papers). Orli Wargon collaborates with scholars based in Australia, United States and Canada. Orli Wargon's co-authors include Susan Adams, Marcia Hogeling, Deshan F. Sebaratnam, Li‐Chuen Wong, Ana Isabel Rodríguez Bandera, Catherine McKay, Tai Anh Phan, Susan Russell, Anne Turner and Ilona J. Frieden and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, PEDIATRICS and The American Journal of Cardiology.

In The Last Decade

Orli Wargon

50 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Orli Wargon Australia 18 868 397 369 269 192 53 1.3k
Kristen E. Holland United States 21 695 0.8× 279 0.7× 482 1.3× 236 0.9× 255 1.3× 48 1.4k
JB Mulliken United States 13 1.4k 1.6× 566 1.4× 391 1.1× 597 2.2× 53 0.3× 21 1.7k
P Vergnes France 15 778 0.9× 228 0.6× 171 0.5× 146 0.5× 34 0.2× 59 1.0k
Marcelo Hochman United States 16 517 0.6× 155 0.4× 140 0.4× 159 0.6× 110 0.6× 44 732
Shahrokh C. Bagheri United States 20 657 0.8× 273 0.7× 194 0.5× 95 0.4× 52 0.3× 54 1.2k
Christopher J. Coombs Australia 17 521 0.6× 277 0.7× 112 0.3× 62 0.2× 51 0.3× 64 853
Samantha A. Spencer United States 18 1.0k 1.2× 159 0.4× 126 0.3× 161 0.6× 29 0.2× 45 1.4k
M C Riché France 12 755 0.9× 450 1.1× 235 0.6× 256 1.0× 43 0.2× 19 926
Metin Önerci Türkiye 21 808 0.9× 76 0.2× 159 0.4× 159 0.6× 86 0.4× 75 1.5k
Lisa M. Buckmiller United States 18 733 0.8× 319 0.8× 270 0.7× 211 0.8× 56 0.3× 27 850

Countries citing papers authored by Orli Wargon

Since Specialization
Citations

This map shows the geographic impact of Orli Wargon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orli Wargon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orli Wargon more than expected).

Fields of papers citing papers by Orli Wargon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Orli Wargon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orli Wargon. The network helps show where Orli Wargon may publish in the future.

Co-authorship network of co-authors of Orli Wargon

This figure shows the co-authorship network connecting the top 25 collaborators of Orli Wargon. A scholar is included among the top collaborators of Orli Wargon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Orli Wargon. Orli Wargon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wargon, Orli, et al.. (2025). The Efficacy and Safety of Atenolol for Treatment of Infantile Hemangioma. JEADV Clinical Practice. 5(1). 153–162.
2.
Joseph, Joseph, et al.. (2024). An outbreak of reactive infectious mucocutaneous eruption (RIME) after Mycoplasma pneumoniae infections in Sydney, 2024: retrospective case series. The Medical Journal of Australia. 221(8). 434–435. 4 indexed citations
3.
Wargon, Orli, et al.. (2023). Gross motor development in children with epidermolysis bullosa. Child Care Health and Development. 50(1). e13194–e13194.
4.
Bandera, Ana Isabel Rodríguez, Deshan F. Sebaratnam, Orli Wargon, & Li‐Chuen Wong. (2021). Infantile hemangioma. Part 1: Epidemiology, pathogenesis, clinical presentation and assessment. Journal of the American Academy of Dermatology. 85(6). 1379–1392. 106 indexed citations
5.
Sebaratnam, Deshan F., et al.. (2021). Infantile hemangioma. Part 2: Management. Journal of the American Academy of Dermatology. 85(6). 1395–1404. 70 indexed citations
6.
Baselga, Eulàlia, Ilona J. Frieden, Christine T. Lauren, et al.. (2020). Characterization of vascular stains associated with high flow. Journal of the American Academy of Dermatology. 84(3). 654–660. 7 indexed citations
7.
Wan, Joy, Eulàlia Baselga, Francine Blei, et al.. (2017). Prenatal Risk Factors for PHACE Syndrome: A Study Using the PHACE Syndrome International Clinical Registry and Genetic Repository. The Journal of Pediatrics. 190. 275–279. 16 indexed citations
8.
Lawson, John A., Vanessa Sarkozy, Kate Riney, et al.. (2017). Early Detection of Tuberous Sclerosis Complex: An Opportunity for Improved Neurodevelopmental Outcome. Pediatric Neurology. 76. 20–26. 29 indexed citations
9.
Russell, Susan, et al.. (2017). Localised intravascular coagulation complicating venous malformations in children: Associations and therapeutic options. Journal of Paediatrics and Child Health. 53(8). 737–741. 40 indexed citations
10.
Wargon, Orli, et al.. (2013). Hypothalamic-Pituitary-Adrenal Axis Recovery Following Prolonged Prednisolone Therapy in Infants. The Journal of Clinical Endocrinology & Metabolism. 98(12). E1936–E1940. 12 indexed citations
11.
Sugo, Ella, et al.. (2013). Proliferative nodules of undifferentiated spindle cells arising in a large congenital melanocytic naevus. Australasian Journal of Dermatology. 55(2). e24–8. 3 indexed citations
12.
Wargon, Orli, et al.. (2012). Effect of captopril on infantile haemangiomas: A retrospective case series. Australasian Journal of Dermatology. 53(3). 216–218. 15 indexed citations
13.
Adams, Susan, et al.. (2011). Childhood wheeze while taking propranolol for treatment of infantile hemangiomas. Pediatric Pulmonology. 47(7). 713–715. 6 indexed citations
14.
Wargon, Orli, et al.. (2011). A Prospective Study of Infantile Hemangiomas with a Focus on Incidence and Risk Factors. Pediatric Dermatology. 28(6). 663–669. 107 indexed citations
15.
Sugo, Ella, et al.. (2011). Juvenile xanthogranuloma: Challenges in complicated cases. Australasian Journal of Dermatology. 52(4). 284–287. 6 indexed citations
16.
Hogeling, Marcia, et al.. (2011). Lymphatic malformations: Clinical course and management in 64 cases. Australasian Journal of Dermatology. 52(3). 186–190. 32 indexed citations
17.
Sugo, Ella, et al.. (2011). Three cases of osteoma cutis occurring in infancy. A brief overview of osteoma cutis and its association with pseudo-pseudohypoparathyroidism. Australasian Journal of Dermatology. 52(2). 127–131. 13 indexed citations
18.
Sugo, Ella, et al.. (2009). Unusual presentation of GLUT‐1 positive infantile haemangioma. Australasian Journal of Dermatology. 50(2). 136–140. 3 indexed citations
19.
Sharan, Sapna, Brighu Swamy, Deepa Taranath, et al.. (2009). Port-wine vascular malformations and glaucoma risk in Sturge-Weber syndrome. Journal of American Association for Pediatric Ophthalmology and Strabismus. 13(4). 374–378. 52 indexed citations
20.
Wargon, Orli, et al.. (2005). Neonatal lupus erythematosus presenting as papules on the feet. Australasian Journal of Dermatology. 46(3). 172–176. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristen E. Holland Breakdown of academic impact, for papers by JB Mulliken Breakdown of academic impact, for papers by P Vergnes Breakdown of academic impact, for papers by Marcelo Hochman Breakdown of academic impact, for papers by Shahrokh C. Bagheri Breakdown of academic impact, for papers by Christopher J. Coombs Breakdown of academic impact, for papers by Samantha A. Spencer Breakdown of academic impact, for papers by M C Riché Breakdown of academic impact, for papers by Metin Önerci Breakdown of academic impact, for papers by Lisa M. Buckmiller
Rankless by CCL
2026